NEC

This early-phase study tests a new drug called HLX3901 in people with advanced small cell lung cancer or neuroendocrine carcinoma that has not responded to other treatments. The drug is a special antibody designed to help the immune system attack cancer cells. The main goals are …

This early-stage study tests whether an oral supplement called L-Citrulline is safe for preterm infants born at or before 30 weeks who have lung disease (BPD), sometimes with high blood pressure in the lungs (PH), or a serious gut condition (NEC). The goal is to see if raising lo…

This study looks at very preterm babies to understand how blood transfusions and feeding practices affect blood flow and oxygen levels in the gut. The goal is to learn why some babies develop a serious gut condition called NEC. Researchers will use non-invasive monitors to track …

This study looks at how the intestines develop normally in premature and full-term babies, and what goes wrong in diseases like necrotizing enterocolitis (NEC). Researchers will collect small tissue samples during surgery or scope procedures, plus blood and stool, to study cells,…